 Cellectar Biosciences NASDAQ:CLRB and Akari Therapeutics NASDAQ:AKTX are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership. Profitability This table compares Cellectar Biosciences and Akari Therapeutics net margins, return on equity and ... 